Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Ivy Rx vs MEDVi

Ivy Rx costs $74 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Ivy Rx logo

Ivy Rx

7.3
★★★★☆3.7/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Ivy Rx →
VS
MEDVi logo

MEDVi

7.1
★★★★☆3.6/5

Best for: knowing which pharmacy fills the vial: it names Triad Rx

Visit MEDVi →

If you are choosing between Ivy Rx and MEDVi, the first difference is cost: Ivy Rx is $74 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Ivy Rx leads our six-part score, 7.3 to 7.1. One of the two has an FDA warning letter on record, covered below.

Ivy Rx vs MEDVi price

Ivy Rx is the cheaper way in: $175 a month against $249 a month at MEDVi. That is $74 less each month (30% lower), or about $888 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Ivy Rx ($175 a month vs $249 a month).

Medications and formats

Both sell semaglutide; only Ivy Rx lists tirzepatide.

On format they match: each offers compounded injections.

Where each one treats patients

Ivy Rx lists 50 states, and MEDVi lists 48 states.

They overlap in 48 states. Ivy Rx alone covers Mississippi and North Dakota.

Pricing

Ivy Rx

StartingCompounded
$175/mo
semaglutide

Range up to $197/mo

StartingCompounded
$275/mo
tirzepatide

Range up to $297/mo

MEDVi

Compounded GLP-1 Injection (weekly)Compounded
$299$179/mo
Save 40% right now
semaglutide

Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.

Compounded GLP-1 Tablets (daily dissolvable)Compounded
$249/mo
semaglutide

Flat 'Starting at $249' — no intro discount shown.

Wegovy Pill / Wegovy Injection (membership fee only; medication cost not published)Brand-name
$99/mo
semaglutide

$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'

Zepbound Injection (membership fee only; medication cost not published)Brand-name
$99/mo
tirzepatide

$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

MEDVi's price also covers coaching, which Ivy Rx does not claim.

Ivy Rx is silent on lab work and coaching.

MEDVi is silent on lab work.

Ivy Rx

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

MEDVi

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, Ivy Rx scores 7.3 and MEDVi 7.1 out of 10.

Ivy Rx is stronger on trust & safety (7.5 vs 6.0).

MEDVi is stronger on support (8.5 vs 7.0).

Value, effectiveness, user experience and accessibility are within half a point.

How we score

Ivy Rx

7.3/10

Overall

MEDVi

7.1/10

Value25%

3.0A
vs
B
2.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
6.0

Accessibility10%

10.0A
vs
B
9.7

Support10%

7.0A
vs
B
8.5

FDA warning letters

The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.

Ivy Rx has no FDA warning letter on record with us.

Features & Coverage

FeatureIvy RxMEDVi
Starting Price✓$175/mo$249/mo
Features3 features✓7 features
States Available✓5048
Compounded✓ Yes✓ Yes
Brand Name—✓ Yes
FSA/HSA Accepted——
FDA Warning Letters✓None1 letter

About Ivy Rx

Ivy Rx is a telehealth seller running tiered compounded semaglutide and tirzepatide programs.

Read our full Ivy Rx review →

About MEDVi

Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.

Read our full MEDVi review →

Pros & Cons

Ivy Rx

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Ivy Rx

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

MEDVi

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves 48 states
  • Names 3 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Ivy Rx

Ivy Rx wins this one, 7.3 to 7.1, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $74 less each month than MEDVi. MEDVi fits better if knowing which pharmacy fills the vial: it names Triad Rx is your priority.

Choose Ivy Rx if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $175 a month.

Choose MEDVi if…

You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

7.7

HealthRX

Compounded semaglutide at $133/month

Ivy Rx vs MEDVi: FAQ

Ivy Rx. It starts at $175 a month; MEDVi starts at $249 a month, $74 more per month.
Yes, both sell semaglutide. Ivy Rx adds tirzepatide.
Ivy Rx: 50 states against 48, with 48 in common.
Both include the clinician visit, the medication itself and shipping. Only MEDVi includes coaching.
Ivy Rx has none. MEDVi has an open FDA warning letter from February 20, 2026.
No. Neither Ivy Rx nor MEDVi pays us anything.

Or see the full category ranking.